•
Dec 31, 2022

Prelude Therapeutics Q4 2022 Earnings Report

EPS
-$0.6
Previous year: -$0.71
-15.5%
Cash and Equivalents
$30.6M
Previous year: $31.8M
-3.8%
Free Cash Flow
-$23.3M
Previous year: -$26M
-10.3%
Total Assets
$221M
Previous year: $305M
-27.7%

Prelude Therapeutics

Prelude Therapeutics